Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M789Revenue (TTM) $M19.3Net Margin (%)-705.5Altman Z-Score-2.8
Enterprise Value $M725EPS (TTM) $-1.3Operating Margin %-551.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score3.8Pre-tax Margin (%)-705.0Higher ROA y-yY
Price/Book16.010-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales40.35-y EBITDA Growth Rate %29.5Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-66.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-119.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXJoel Greenblatt 2016-03-31 Buy $3.17 - $5.38
($3.99)
$ 7.5389%New holding25,457
KERXSeth Klarman 2015-06-30 Add0.57%$9.32 - $12.73
($10.75)
$ 7.53-30%Add 15.24%25,791,678
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
($12.86)
$ 7.53-41%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 7.53-51%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 7.53-47%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 7.53-50%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Adams BrianVP and General Counsel 2016-07-15Sell1,083$7.017.42view
Adams BrianVP and General Counsel 2016-07-05Sell660$6.6613.06view
Madison GregPresident and CEO 2016-07-05Sell936$6.6613.06view
Madison GregPresident and CEO 2016-05-09Sell1,873$5.4238.93view
Neylan John F.Chief Medical Officer 2016-04-25Sell4,766$5.2144.53view
Adams BrianVP and General Counsel 2016-04-15Sell1,060$5.0549.11view
Madison GregPresident and CEO 2016-04-05Sell1,078$4.567.33view
Adams BrianVP and General Counsel 2016-04-05Sell759$4.567.33view
Madison GregPresident and CEO 2016-02-09Sell1,938$3.23133.13view
Adams BrianVP and General Counsel 2016-01-15Sell1,322$3.3128.18view

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 
Seth Klarman Raises Position in Keryx Biopharmaceuticals Oct 21 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 

More From Other Websites
Will Keryx Biopharmaceuticals (KERX) Continue to Surge Higher? Jul 19 2016
Coverage Initiated on Select Biotech Stocks Jul 15 2016
[$$] Keryx Stock Seen Reaching $9 Jul 11 2016
ETF’s with exposure to Keryx Biopharmaceuticals, Inc. : July 6, 2016 Jul 06 2016
5 Hot Stocks to Watch Right Now Jun 30 2016
Cramer: If the data's good, this stock could get a takeout bid Jun 27 2016
Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy Jun 27 2016
Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy Jun 27 2016
Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors Jun 23 2016
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Jun 21 2016
Keryx Biopharmaceuticals Appoints Two New Board Members Jun 21 2016
Keryx Biopharmaceuticals Appoints Two New Board Members Jun 21 2016
Premarket Research Report Covering the Biotech Industry Jun 15 2016
Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21 Jun 14 2016
Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21 Jun 14 2016
6 Biotechs Seriously on the Move Jun 02 2016
Here's a Reason Why Keryx (KERX) Stock Is Spiking Today Jun 02 2016
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... May 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)